Pregnancy outcome in systemic lupus erythematosus complicated by anti-phospholipid antibodies
Authors:
Open Access
- 17 October 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 48 (3) , 246-249
Abstract
Objective. Pregnant women affected by SLE are at high risk of gestational hypertension and pre-eclampsia (32–50%). This risk is particularly elevated if aPLs are dosable. The present study was planned to evaluate maternal–fetal outcomes of different groups of SLE pregnant patients characterized by diverse risk factors: patients affected by APS treated with a combination of low-dose aspirin (LDA) and low-molecular weight heparin (LMWH), nulliparous patients with dosable aPL treated by LMWH and SLE patients with no aPL administered no treatment during pregnancy. Methods. A retrospective description of maternal and fetal outcomes was made in a total of 62 pregnancies presenting APS in 8 cases (12.9%), aPL in 20 (32.2%) and no aPL in 34 (54.8%). Results. No statistically significant difference was found comparing fetal and maternal outcomes of the three groups despite differences in SLE activity: SLE aPL-positive pregnancies were associated with a higher incidence of nephritis and chronic hypertension than pregnancies treated for APS or not presenting with the added risk factor. The incidence of pre-eclampsia is 15% in aPL positive, 12.5% in APS and 14.7% in no aPL pregnancies, respectively. Conclusions. LMWH is rather a possible option of prophylaxis for SLE aPL-positive pregnancies with potential maternal–fetal outcomes similar to aPL-negative patients or to standard treated APS.Keywords
This publication has 21 references indexed in Scilit:
- Introduction: new trends in pregnancy and rheumatic diseasesRheumatology, 2008
- Systemic lupus erythematosusThe Lancet, 2007
- Antiphospholipid syndrome: obstetric diagnosis, management, and controversiesObstetrics & Gynecology, 2003
- Multiple Autoantibodies Associated with Autoimmune Reproductive FailureJournal of Assisted Reproduction and Genetics, 2003
- The Antiphospholipid SyndromeNew England Journal of Medicine, 2002
- Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1997
- OBSTETRIC MANAGEMENT OF THE HIGH-RISK LUPUS PREGNANCYRheumatic Disease Clinics of North America, 1997
- Practical assessment of neonatal nutrition status beyond birthweight: an imperative for the 1990sBJOG: An International Journal of Obstetrics & Gynaecology, 1994
- Derivation of the sledai. A disease activity index for lupus patientsArthritis & Rheumatism, 1992
- Assessment of Fetal GrowthClinics in Perinatology, 1986